OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FTX contributes to cell proliferation and migration in lung adenocarcinoma via targeting miR-335-5p/NUCB2 axis
Xiaodong Huo, Huixing Wang, Bin Huo, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma
Peng Song, Wenbin Li, Xiaoxuan Wu, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 10, pp. 2341-2354
Closed Access | Times Cited: 41

SLC7A8 overexpression inhibits the growth and metastasis of lung adenocarcinoma and is correlated with a dismal prognosis
Fang‐Ming Wang, Liqiang Xu, Zhongchao Zhang, et al.
Aging (2024) Vol. 16, Iss. 2, pp. 1605-1619
Open Access | Times Cited: 4

Emerging roles of long non-coding RNA FTX in human disorders
Mohadeseh Sheykhi-Sabzehpoush, Majid Ghasemian, Fatemeh Khojasteh Pour, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 10, pp. 2812-2831
Closed Access | Times Cited: 10

NUCB2 inhibition antagonizes osteosarcoma progression and promotes anti-tumor immunity through inactivating NUCKS1/CXCL8 axis
Renchen Ji, Yuan Wang, Deyue Pan, et al.
Cancer Letters (2024) Vol. 591, pp. 216893-216893
Closed Access | Times Cited: 3

YY1-Induced lncRNA PART1 Enhanced Resistance of Ovarian Cancer Cells to Cisplatin by Regulating miR-512-3p/CHRAC1 Axis
Hongbo Yang, Xuegang Zhang, Li Zhu, et al.
DNA and Cell Biology (2021) Vol. 40, Iss. 6, pp. 821-832
Closed Access | Times Cited: 22

Biological role of long non-coding RNA FTX in cancer progression
Jinlan Yang, Tianyin Qu, Yajun Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113446-113446
Open Access | Times Cited: 14

LncRNA FTX promotes the malignant progression of colorectal cancer by regulating the miR-214-5p–JAG1 axis
Luxiang Pan, Ming‐Rui Du, Haixia Liu, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 17, pp. 1369-1369
Open Access | Times Cited: 15

Tumour suppressor role of microRNA-335-5p in esophageal squamous cell carcinoma by targeting TTK (Mps1)
Geetika Suyal, Prerna Pandey, Anoop Saraya, et al.
Experimental and Molecular Pathology (2021) Vol. 124, pp. 104738-104738
Closed Access | Times Cited: 14

Nucleobindin-2/Nesfatin-1—A New Cancer Related Molecule?
Alicja Kmiecik, Piotr Dzięgiel, Marzenna Podhorska‐Okołów
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8313-8313
Open Access | Times Cited: 13

Long non‑coding RNA SNHG7 facilitates pancreatic cancer progression by regulating the miR‑146b‑5p/Robo1 axis
Jian Yu, Qi Fan
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 4
Open Access | Times Cited: 10

The Multifaceted Nature of Nucleobindin-2 in Carcinogenesis
Anna Skorupska, Rafał Lenda, Andrzej Ożyhar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5687-5687
Open Access | Times Cited: 10

NUCB2: roles in physiology and pathology
Qing Zhou, Ying Liu, Ranran Feng, et al.
Journal of Physiology and Biochemistry (2022) Vol. 78, Iss. 3, pp. 603-617
Closed Access | Times Cited: 5

MiR-30a-5p inhibits proliferation, migration and invasion of nasopharyngeal carcinoma cells by targeting NUCB2
M Li, Y Wang, Qinqin Zhao, et al.
Human & Experimental Toxicology (2021) Vol. 40, Iss. 8, pp. 1274-1285
Open Access | Times Cited: 6

Nucleobindin-2 consists of two structural components: The Zn2+-sensitive N-terminal half, consisting of nesfatin-1 and -2, and the Ca2+-sensitive C-terminal half, consisting of nesfatin-3
Dominika Bystranowska, Anna Skorupska, Katarzyna Sołtys, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4300-4318
Open Access | Times Cited: 6

Long noncoding RNA FTX promotes epithelial-mesenchymal transition of epithelial ovarian cancer through modulating miR-7515/TPD52 and activating Met/Akt/mTOR.
Yong Li, Xinghua Zhu, Can Zhang, et al.
PubMed (2023) Vol. 38, Iss. 12, pp. 1487-1498
Closed Access | Times Cited: 2

Towards Understanding the Key Signature Pathways Associated from Differentially Expressed Gene Analysis in an Indian Prostate Cancer Cohort
Nidhi Shukla, Bhumandeep Kour, Devendra Sharma, et al.
Diseases (2023) Vol. 11, Iss. 2, pp. 72-72
Open Access | Times Cited: 2

Identification and analysis of genes associated with lung adenocarcinoma by integrated bioinformatics methods
Hui Xie, Jian‐Fang Zhang, Qing Li
Annals of Human Genetics (2021) Vol. 85, Iss. 3-4, pp. 125-137
Closed Access | Times Cited: 4

NUCB2 promotes hepatocellular carcinoma cell growth and metastasis by activating the E2F4/PTGR1 axis
Yuan Wang, Bin Sun, Wei Wei, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 12, pp. 4767-4780
Open Access

Upregulation of FTX expression is associated with a poor prognosis and contributes to the progression of thyroid cancer
Ping Wang, Yongming Zhang, Wenping Wang, et al.
Oncology Letters (2021) Vol. 22, Iss. 3
Open Access | Times Cited: 3

NUCB-2/Nesfatin-1 promotes the proliferation of nasopharyngeal carcinoma cells
Yunlai Liang, Yating Ma, Kun Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top